Mitochondria are known to actively regulate cell death with the final phenotype of demise being determined by the metabolic and energetic status of the cell.
INTRODUCTION
Mitochondria play a central role in various forms of cell death which are characterized by differential biochemical features that include apoptosis (caspase-dependent and independent), necrosis and autophagy. A key event in this role is the breakage of mitochondrial membranes, particularly the outer mitochondrial membrane, which allows the release of proapoptotic factors that engage the apoptosome resulting in apoptotic cell death. Understanding the mechanisms leading to mitochondrial membrane permeabilization (MMP) is thus central to the design of estrategies to control cell death. In pathologies associated with enhanced cell death such as liver diseases (e.g. steatohepatitis) or neurodegeneration (e.g. Alzheimer´s disease), the therapeutic goal is to prevent or ameliorate the extent of cell death. In contrast, in cancer the primary interest is to kill tumor cells more efficiently sensitizing them to current cancer therapy.
Although a major focus in the field has been paid on the role of Bcl-2 family members in the regulation of MMP and cell death [1, 2] , an increasing body of evidence points to a key role of lipids in the regulation of MMP and cell death susceptibility. In particular, mitochondrial cholesterol has emerged as an important modulator of MMP in response to apoptotic stimuli including hypoxia, TNF, amyloid beta peptide (A ) or Bax, underlying the importance of this particular bilayer component in disease pathogenesis, including alcoholic and nonalcoholic steatohepatitis, Alzheimer´s disease or hepatocellular carcinoma [3, 4] . Although the unphysiological accumulation of cholesterol shields mitochondrial membranes impairing the bilayer permeabilization, as shown in model membranes, this effect can be counterbalanced by the presence of peroxidized cardiolipin, which is in turn regulated by the availability of mitochondrial GSH (mGSH) [3] . Thus, mitochondrial cholesterol plays a paradoxical role in cell death depending on the regulation of mitochondrial GSH (mGSH) transport, mGSH 4 homeostasis and subsequent protection of cardiolipin from peroxidation. In this review, we will briefly summarize the implications of the enrichment of mitochondrial membranes in cholesterol and its impact in mitochondrial membrane properties, mGSH regulation, cardiolipin status, and cell death.
MITOCHONDRIAL PATHWAY OF CELL DEATH
Apoptosis is a specific form of cell death which is essential for life as it is required for embryonic development, tissue homeostasis and immune defense. Dysregulation of apoptosis, however, contributes to many pathophysiological states and diseases. The key mediators of apoptotic cell death are cysteine proteases, called caspases, that work in a coordinated cascade to cleave key substrates that dismantle the cell with characteristic biochemical features [5, 6] . Apoptosis can occur through two main pathways, the extrinsic pathway and the intrinsic pathway. The former is initiated upon the binding of an extracellular ligand to transmembrane death receptors of the TNF supefamily, which leads to the assembly of the death-inducing signalling complex (DISC) [7, 8] . The DISC then activates an initiator caspase, which triggers the enzymatic cascade that leads to apoptotic death. The intrinsic pathway is also known as the mitochondrial pathway and is activated by stimuli that lead to the permeabilization of mitochondrial outer membrane (MOM) and the subsequent release of proteins, such as cytochrome c, from the mitochondrial intermembrane space (IMS), which initiate and regulate caspase activation.
Cytochrome c normally resides within the cristae of the mitochondrial inner membrane (MIM) and is effectively sequestered by narrow cristae junctions. Within the MIM, cytochrome c participates in the mitochrondrial electron-transport chain, using its haem group as a redox intermediate to shuttle electrons between complex III and complex IV.
However, in response to specific apoptotic triggers, such as DNA damage, or metabolic stress, the intrinsic apoptotic pathway is activated and mitochondrial cytochrome c is released into the cytosol [2] . This process is thougth to occur in two phases, first the mobilization of cytochrome c and then its translocation through permeabilized MOM, described below. In addition to cytochrome c, other IMS proteins are mobilized and released into the cytosol. For instance, the release of Smac/Diablo into the cytosol ensures the efficiency of caspase 3 activation in degrading target proteins through inhibition of inhibitor of apoptosis proteins (IAPs) [9, 10] . Furthermore, the mitochondrial protein Omi/HtrA2 promotes cell death in a dual fashion. Besides its IAP activity Omi/HtrA2 also functions as a serine protease, contributing to both caspasedependent and caspase-independent cell death [11, 12] . Moreover, other specialized mitochondria-resident proteins, such as the apoptosis inducing factor (AIF) [13] and endonuclease G [14] , are translocated to the nuclei following their release from mitochondria and promote peripheral chromatin condensation and high molecular weight DNA fragmentation. An important feature of apoptosis is its dependence on energy by sustained ATP supply to support caspase activation [2, 5, 6] .
In contrast to apoptotic cell death, necrotic cell death is characterized primarily by the rapid loss of cellular membrane potential, which leads to cytoplasmic swelling, rupture of the plasma membrane, and cytolysis. The extent of mitochondrial dysfunction and the rupture of MIM impairs the ability of mitochondria to generate ATP, needed for the function of homeostatic ion pumps/channels, and the generation of reactive oxygen and nitrogen species (ROS/RNS), which in turn, can regulate caspase activation [15] . The onset of necrotic cell death can also occur in the extrinsic pathway by death receptors, such as TNF or Fas. FADD, a DISC component, has been shown to be involved in TNF-induced necrosis [16, 17] . RIP1 also contributes to death receptor-induced necrosis, as RIP1-deficient T cells are also resistant to death induced by TNF and Fas in the presence of caspase inhibitors [17] . The kinase activity of RIP appears to be required for necrosis induction, although its targets remain to be identified. Necrostatin-1, a small molecule that can inhibit necrosis induced by RIP or by TNF and Fas in the presence of caspase inhibitor [18] , may be a valuable tool to disclose signaling pathways involved in death receptor-mediated necrosis. Thus, while mitochondria play a key role in the control of cell death, the phenotype of the dying cell depends on the metabolic and energetic status of the cell that determine the level and extent of caspase activation.
3.MITOCHONDRIAL MEMBRANE PERMEABILIZATION AND

CYTOCHROME C RELEASE
The mechanisms of MMP and cytochrome c release from IMS have been an intense area of research, whose understanding may be important to control cell death. Indeed, this is a critical issue because, in addition to cytochrome c, other proteins are also released from the intermembrane space into the cytosol, where they engage in a strategic battle to promote or counteract caspase activation and hence cell death, as described above. The intricacy of this pathway highlights the central role of mitochondria in regulating cell death, regardless of the phenotype of death (caspasedependent apoptosis, caspase-independent apoptosis, or necrosis). Since these proapoptotic proteins are normally confined in the IMS, the events that culminate in the rupture of the physical barrier (MOM), which limits their release into the cytosol, constitute a point-of-no-return in cell death [2] . While the underlying mechanisms are In addition to understanding the mechanisms leading to MOM permeabilization to design strategies to control cell death, another level of control centers on the mechanisms underlying the mobilization of cytochrome c from IMS. It has been proposed that during mobilization cytochrome c detaches from the MIM and dissociates from the membrane phospholipid cardiolipin [27] . A significant proportion of the cytochrome c in the mitochondria seems to be associated with cardiolipin, involving two major mechanisms. At physiological pH, cytochrome c has 8 positive net charges, establishing an electrostatic bond with the anionic cardiolipin. In addition, cytochrome c has a hydrophobic channel through which one acyl chain of cardiolipin inserts. The other chains of cardiolipin remain in the membrane, thereby anchoring cytochrome c to 9 the MIM [28] . One mechanism involved in cytochrome c detachment from MIM involves cardiolipin oxidation because oxidized cardiolipin has a lower affinity for cytochrome c than the unoxidized form [29, 30] . Cardiolipin can be oxidized by ROS, which are controlled by mitochondrial antioxidants such as GSH [30, 31] or by the cardiolipin-cytochrome c complex [32] . Detachment of cytochrome c from cardiolipin might also be triggered by increased cytosolic Ca 2+ , which weakens the electrostatic interaction between cytochrome c and cardiolipin. In addition, as described below, oxidized cardiolipin modulates the biophysical properties of MOM to allow oligomerized Bax to insert and permeabilized MOM [30] .
In contrast to this view, other evidence neglects the mobilization of cytochrome c from MIM as a requirement for its release into the cytosol. In isolated mitochondria, exposure to 50-80 mM K + , a concentration of intracellular K + that is within physiological limits, causes the release cytochrome c from the IMM [33] . In addition, live-cell imaging has revealed no differences in the kinetics of the release of cytochrome c compared with other IMS proteins in cells undergoing apoptosis [34] . These results imply that cytochrome c mobilization might not require an additional step in its release from the mitochondria. In addition, mobilization of cytochrome c might also involve its removal from narrow cristae junctions, although this specific issue is controversial. For instance, it has been suggested that the remodelling of cristae is required in the release of this interior pool of cytochrome c [35] , and recent studies correlated the disassembly of Opa1 oligomers, a structural determinant of cristae morphology, with the remodelling of cristae [36] . However, using three-dimensional electron microscope tomograpy, it has been shown that cristae remodelling is not required for efficient release of cytochrome c [37] . Moreover, BH3-only proteins Bid and Bim induced full cytochrome c release but only a subtle alteration in cristae junctions, which involved the disassembly of Opa1 complexes [38] .
CHOLESTEROL IN MITOCHONDRIAL MEMBRANE PROPERTIES, MMP AND CELL DEATH
Cholesterol is a critical component of membranes with key structural and functional roles [39] . Compared to plasma membrane mitochondria are cholesterol-poor organelles with estimates of about 3-5% of the total cholesterol cell load. However, this restricted pool of cholesterol in mitochondria plays a fundamental physiological role such as in the synthesis of bile acids in hepatocytes or steroidogenic hormones in specialized tissues [3] . Given the role of cholesterol in the regulation of membrane dynamics and physical properties, the synthesis and supply of membrane cholesterol is highly regulated under physiological conditions. Cholesterol is synthesized in the ER and delivered to other organelles, including mitochondria, by a combination of vesicular and non-vesicular transport processes [39, 40] . Since cholesterol is very insoluble in water, it must be shuttled by carriers. The mechanisms of non-vesicular cholesterol transport are poorly understood, although there is increasing evidence that this is the major route for cholesterol movement between organelles. In the case of cholesterol trafficking to mitochondria, the best characterized example of non-vesicular mechanism involves the steroidogenic acute regulatory protein (StAR), which is the prototype for the StARrelated lipid transfer (START) family of transport proteins. StAR plays an essential role in the delivery of cholesterol to mitochondria, where it is used in steroid hormone synthesis in steroidogenic tissues or in the acidic pathway of bile acid synthesis in hepatocytes [39, 41] . Cholesterol is known to regulate membrane physical properties and membrane organization. In particular cholesterol regulates the coexistence within membranes of lipid-disordered and lipid-ordered phases, which regulates their permeability and function of resident proteins. In this regard, it has been shown that cholesterol loading in mitochondria results in increased membrane order parameter which impacts negatively in specific membrane carriers, such as the GSH transport system without effect in others, including the S-adenosyl-L-methionine transport system [42] . Since GSH is synthesized de novo exclusively in the cytosol but not in mitochondria, the mitochondrial source of GSH depends on its transport from cytosol by the 2-oxoglutarate and dicarboxylates carriers, which have been previously characterized [43, 44] . Functional expression studies in Xenopus laevis oocytes provided clear evidence that the 2-oxoglutarate carrier is highly sensitive to mitochondrial membrane fluidity loss induced by cholesterol loading [44] . Coupled with previous findings showing low and high affinity components for the mitochondrial transport of GSH into rat liver mitochondria, the 2-oxoglutarate carrier accounts for the low affinity transport site with the dicarboxylate playing a minor role. Thus, one of the functional consequences of mitochondrial cholesterol enrichment is the impairment of mitochondrial GSH (mGSH) transport which results in its depletion in the mitochondrial matrix, promoting the stimulation of mitochondrial ROS induced by death ligands (e.g. TNF) (Figure 1 ). This paradigm would favor the peroxidation of cardiolipin by enhanced ROS, which destabilizes the lipid bilayer potentiating MOM and subsequent release of cytochrome c. Since GD3 is a key component of raft like domains and shown to promote MOM [15] , it is conceivable that the enhanced mitochondrial cholesterol loading may result also in the enrichment of GD3 in specific domains of mitochondrial membranes possibly associated with peroxidized cardiolipin, although this remains to be established.
Mitochondrial cholesterol in liver diseases and neurodegeneration
One of the most common forms of liver disease worldwide is steatohepatitis, which encompasses both alcoholic (ASH) and nonalcoholic steatohepatitis (NASH). While the pathogenesis of these diseases are obviously different, they exhibit indistinguisable histological features and commom underlying mechanisms of disease progression that start with hepatic steatosis. Although fat infiltration in these diseases is heterogenous consisting primarily of triglyceride, free fatty acids and cholesterol, recent studies have pointed to an emerging role for cholesterol, particularly in mitochondria, in the progression from steatosis to steatohepatitis as it sensitizes hepatocytes to inflammatory cytokines (e.g. TNF/Fas ligand) [45] . Moreover, massive triglyceride accumulation in the liver of transgenic mice overexpressing DGAT2 did not impair insulin sensitivity, a hallmark feature of NASH [46] . In addition, unchanged hepatic free fatty acids levels were reported in patients with NASH compared to healthy controls, while the degree of free cholesterol accumulation correlated with disease progression [47, 48] . The underlying mechanism for the sensitization of mitochondrial cholesterol-loaded hepatocytes to TNF/Fas and hence steatohepatitis involved the selective mGSH depletion, an outcome also observed in models of ASH [43, 45] which is thought to play a key role in AD [4] . Indeed, using longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice, it was observed that A plaques formed very quickly, within 24 h.
Following plaque's appearance, microglia become activated and recruited to the site.
Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks, thus critically establishing that A plaque formation precedes disease progression [49] . In addition to aging, epidemiological observations identified hipercolesterolemia as a major risk factor for sporadic AD [4, 50, 51] . In this regard, the role of statins in AD, however, has been controversial, although the epidemiological evidence linking cholesterol to AD has been supported by in vivo and in vitro data. Indeed, since the amiloidogenic processing of the amyloid precursor protein by the presenilin1/ -secretase is thought to occur in specific microdomains of the plasma membrane, cholesterol enrichment favors the generation of A peptide and hence neurite degeneration [52] . Consistent with the mitochondrial targeting of A as a major mechanism involved in A -induced neurotoxicity, the specific role of mitochondrial cholesterol in this context has been recently evaluated. Using genetic mouse models of cholesterol accumulation, it was 14 observed mitochondrial cholesterol enrichment in transgenic SREBP-2 and NPC1 knockout mice which determined enhanced susceptibility to A -mediated neuroinflammation and neurotoxicity due to mGSH depletion [53] . Moreover, APP/PS1 transgenic mice exhibited enhanced mitochondrial cholesterol loading and subsequent mGSH depletion. Isolated mitochondria from these mice exhibited increased susceptibility to A -mediated cytochrome c and Smac/Diablo release, indicative of MMP, and caspase activation than wild type mice. Of relevance, the onset of AD symptons in vivo were prevented by mGSH recovery with GSH ethyl ester, thus pointing that strategies aimed to boost this particular pool of GSH may be of potential relevance in AD.
Mitochondrial cholesterol and cancer therapy
Cancer cells exhibit critical metabolic transformations regarding the cholesterol homeostasis best illustrated by the ability of solid tumors to synthesize cholesterol under hypoxia, which contrasts with the physiological requirement for oxygen in the transformation of lanosterol into cholesterol involving 9 redox reactions [3, 39] . Moreover, recent observations indicated that hypoxia stimulates the degradation of HMG-CoA reductase, ther rate-limiting enzyme in cholesterol synthesis [54] . In addition to this continued cholesterol synthesis in growing tumor cells, we have recently observed the stimulation of cholesterol trafficking to mitochondria from hepatocellular carcinoma (HCC) cells due to the overexpression of StAR [55] . Previous studies have shown that cholesterol enrichment of rat liver mitochondria impairs the ability of atractyloside to induce MPT [56] , which suggest that mitochondrial cholesterol loading may actually account for the recognized mitochondrial dysfunction occurring in cancer cells (Figure 2) . Observations in HeLa cells treated with U18666A, which results in mitochondrial cholesterol loading, indicated a delayed release of Smac/Diablo and cytochrome c, as well as in BAX oligomerization and partial protection against stress-induced apoptosis [57] .
Consistent with our findings in HCC, data from liposomes entrapping fluorescent dextrans indicated that the presence of cholesterol in the bilayer impaired Bax-mediated permeabilization due to the combination of reduced membrane dynamics and decreased
Bax integration into the bilayer [55] . Moreover, the silencing of StAR downregulated mitochondrial cholesterol levels and sensitized HCC cells to chemotherapy, similar to the findings observed with statins or squalene synthase inhibition, which resulted in downregulation of cholesterol loading [55] . Thus these findings clearly identify the mitochondrial cholesterol pool as a novel mechanism whereby cancer cells, particularly HCC resist chemotherapy and evade Bax-mediated MMP and subsequent apoptosis.
ROLE OF CARDIOLIPIN/PEROXIDIZED CARDIOLIPIN IN CELL DEATH
Cardiolipin is a mitochondria-specific phospholipid, which plays an essential role in the organization of mitochondrial electron transport complexes involved in the generation of energy [27] . Accumulating evidence suggests that this unique lipid also has an active role in several of the mitochondria-dependent steps of apoptosis, namely, in the regulation of MOM, mobilization of cytochrome, and more recently, in the anchoring of caspase-8 to mitochondria during death receptor-induced apoptosis [58] . Mature cardiolipin is synthesized by the sequential participation of phospholipase A, which removes one saturated acyl chain to generate monolysocardiolipin, and by tafazzin, a mitochondrial enzyme that catalyzes the addition of an unsaturated chain to monolysocardiolipin [59] . It provides a docking site for the interaction and activation of Another novel function of cardiolipin in cell death, has been the recently described effect in regulating the activation of apycal caspase-8 in type II cells [58] . Following an external stimuli, caspase-8 translocated to mitochondria to bind to sites enriched in cardiolipin resulting in its proteolytic activation. Interestingly, recent evidence indicated that these activating platforms enriched in cardiolipin corresponds to sites also enriched in ganglioside GD3 and cholesterol, suggesting the presence of raft-like domains, which have been described in cells undergoing apoptosis [61, 62] . Therefore, cardiolipin is an has been shown to reside [63] . In addition, Bid and mostly tBid exhibit lipid transfer activity contributing to the transbilayer movement of cardiolipin to the outer membrane [64, 65] . Moreover, phospholipid scramblases (PLS) induce non-specific bi-directional movement of phospholipids across the membrane. In particularly PLS3, a mitochondrial located PLS, has been shown to translocate cardiolipin from the MIM to the MOM during apoptosis induced by UV-irradiation [66, 67] . Nevertheless, regardless of the exact mechanism(s) involved, the translocation of cardiolipin between mitochondrial membranes has profound consequences in the mitochondrial apoptotic pathway, regulating the release of cytochrome c, mitochondrial bioenergetics and membrane perturbing effects such as the formation of cardiolipin-enriched microdomains, cristae remodelling and the accumulation of lyso-phospholipids. Further studies will be needed to establish if cholesterol, sphingolipids (e.g. GD3) and (peroxidized) cardiolipin are part of specific signaling domains which regulate the critcal steps of mitochondrial pathways of cell death.
CONCLUSIONS
As an integral component, cholesterol plays an important role in the structure, physical properties and function of biological membranes. In particular, the mitohondrial cholesterol pool, which represents a minor proportion of the total cholesterol load, is emerging as an important factor in the regulation of mitochondrial membrane permeabilization and cell death. The enrichment of cholesterol in mitochondrial membranes determines the progression of liver and neurodegenerative diseases, and the resistance of cancer cells to current cancer therapy. Much of this effect of cholesterol is due to the changes in physical properties of mitochondrial membranes, especially in the appearance of lipid-ordered phases and subsequent loss of membrane fluidity that impairs mitochondrial function and specific membrane carriers. In particular, cholesterol loading in mitochondrial membranes selectively affects the transport of GSH into the matrix resulting in its depletion, which has a major impact on the stimulation of oxidant species derived from mitochondrial electron transport chain. As a consequence, cardiolipin becomes peroxidized, facilitating the redistribution of free cytochrome c to the intermembrane space and the permeabilization of mitochondrial outer membrane by Bax. Intriguingly, cholesterol plays a paradoxical role in cell death, being proapoptotic or antiapoptotic depending on whether mitochondrial GSH is depleted or not (Figure 2) , which is in turn associated with the cardiolipin/peroxidized cardiolipin status. Thus, targeting mitochondrial cholesterol either by restraining its trafficking to or within mitochondrial membranes via StAR family members or by decreasing its availability (e.g. ezetimide or statins) may be of relevance for a number of pathologies such as steatohepatitis, neurodegenerative diseases or cancer.
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